_ID | Prediction | OTHER | SP | mTP | CS_Position | |
---|---|---|---|---|---|---|
PY17X_1337500 | SP | 0.110974 | 0.888783 | 0.000242 | CS pos: 21-22. TKS-IK. Pr: 0.9425 |
MISIFLSILLFVLIFENPTKSIKIRNTYYMHMYNNVNINNFAEKETRGQYPNRKGTNDVL SENYRNKFMPLFVSKGTNILNSILKNKTFRYIYNDPERNTKKNSKNNSKNLAFLYTLHKH SNTLSRISKSKSFQGDDIEKLENNNDEDNDSTNNISSRSNSNDIDKTYSFDHIGNNLNED PEKKIFSFTSNRKDAQSGFRDDSNSSYITKDNLKKKSDSVNNREKKVLENLIDNFSNLNW SNNIIDDANLNQPQYSKEFGSYIKSENDKSLHYYSDGILDHLYSYKKFSTKNKKKKNLNK LFYSFKPLENVHTIKKGTITAQPIQNNAEIGTPLSHSDKNGISMSNINKRQIKFGDKRIY MKKGDTCERDENEHIDDTEFLTYEETNNIKKKAYKDYINYINERRYPYINYLKMKNEKII KKLLIANNGMAALKCILSLKEWLFKTFNDENLIQIIVLATEDDIKSNSKYISLSDKVIKV PPGKNSYNYANVSLIVDIAKKENVDAVWPGWGHCSENPLLSSMLEKENIIFVGPTDNVME ALGDKISANILAQSVNVPVVKWSGDNLKIKDFENNSISQDIYNKSTIHSLEECIRECKRI GYPVMIKASQGGGGKGIRKVENENEIKKYYEQVQNELPNSPIFLMKVCSNVRHIEIQVVG DMYGNVCSLSGRDCTTQRRFQKIFEEGPPSIVPPHTFREMEKASIRLTKMIKYRGAGTIE YLYDQVNNKYYFLELNTRLQVEHPVSEGITDTNIVAIQLQVAMGIPLQNIDDIKKLYKIE EKTKKNTSSSSVSIVNDKLKLPISEKDNNKTVKTNLSEQLGMFDFYNNMPHTKNHVIAAR ITAENSNDSFKPTSGLVKNVNFQNSKDVWGYFSINNGFVHEFSDSQIGHIFAKGETREIA RKNLILALRKLSIDGEIKTVTKYLAKILESKAFIDNNITTNWLDVVIERKKNIYYNAFHI IILCAAIFKLLIYFMKEMENTEDSLNREDIAIKSENNINDISLNGKMKRAHIFDIIFQNV KYKFKGYNTGEDLYKLNINDQEIEILAKYDKENNKIFASFHNQTYIYTCIEDSLGTHMNL GKDNVFIPVITNPYHLISNTNGKIVKYLIKDGEKINKFDDYIEVEAMKMIMTFKSTETGI LKHKMSEGAMIKIGDLLGVIEKEKDNQNYQNDDNNNKIIDFIGHLNLSNKNAYELNGTFV PDLAEESHNNEVCCKNIEKEKMENLRKIEDPKNNKIYPTKHTNRNSQVNTTNESVSVQDI KTENMKKDESQFCTEDKQIQNNQVNRRNKLFLKKNNGKNNKNNMFRLFSQKNDNDSKIID SNIESNSRDDTLSYDKINKKNTNNESLKATKKEPKDATNMLETTKETSIGSKNYLNEKLN SVKKYLTNLNLSITNTINKMSTTPNEELINDISENNLSTTNTMHNDSIVNSGSNDSLVSQ RTNNISEEKIDNNKKLISYDNYKNQSYKDKIVSSEIDFPVNNTKDKKLDKMKIISDTEMS RSNDDNSQSSRNRTNTNYNEKIELNFDNKKDKENEFFLELSNMKRIEYLLKGYEQDYEKC FEDFLKDKNNFDKNLNYILDKFIEYNHLFSKKEIISEVEIYYILYKSISDKKKQYEIIHA YTYNYLSIKLLEKILNNLINSKQTNLSLQILNKIKILKEFKGKIFGSIILLSRYIIYLYE QNEKIHYLESSFQYNKNMEDMKKQSLQNYIRFLTKSSNMDNYKIDQILNNTNYEEKIKLF LKSPSDIHYSLPFLFKTENVNYQEMFNTYLHNLYKYSTIKAKPHSPNCLVFSINNHEYNN VMLNLNEDITIEQFKSMLDDILYEMKSDKINTFHIINKNETFFNSLQNYLDNAFKKVNTL YIYNYFGNKYGEIHKINMNAYKEREKIQDNLEKSPIETNKNDSTINNKIYLLPFEEEILT SENIASNFELKNVGQEVFNKTKILLGTYKQNNKYTSLFAQRIIDINDLQKQVDSDNIKVY DEQENVGMTKNGKNNILLSKNIENGQMNNQIYDIFMSELKESIEDISIYRLNPSIRDIKI SSNIIYHIVLPNNSNIEDQINGIKEIYKNFLNKYNELFIENYVNNVYIKVYKEIEEEKNN ETKLELNQLLKLHVLFDNEKEVIEKVDKINPVIIDALYLKRKRARDVDTIYAYDFVKLIN IALNRINNTLNDNFNYINSVKEFKIDYSRENSEEINDTVSVGKKEKSQPNKNDKQSKWLF ENFDNLSSDEIRIKKSLYLSNSLEIGQNKMSVIGLLMNVKTDEYKEGRDIAFIINDITTN GGAFSVLEDELFYGVSCYAREKKIPRICISCNSGAKIGLYNYLMDKIKVCWNDENKKELG YKYIYITEEVKETIPKKDIIYLREIYENGEKRYIIDAIVGNLNNHIGVENLRGSGLIAGE TSKAYDEIFTLSYVTGRSVGIGAYLVRLGKRTIQKKGSSLLLTGFNALNKILGEKVYISN EQLGGVNIMMKNGISQLEAENDQDGVNKIFKWLSYVPKTSDNYFDVLGESTKSFHNKLQE DNKCDITKSRNLNNSIDSDQQSNNYPNGYINDQDIQEYAKKNSLHSSSDSTTVEPESIKE CDTSLIHINGNNGDEESGNEISDTISDNWNKINDVDMDNVNEADIIELLKGSDKKQGFLD KNSYFEYMNEWGKGIITGRGKLGSIPIGFIAVNKNLVTQTVPCDPALKTKAIKTTNAPCV FVPDNSYKTAQSIEDFNKENLPLFVFANWRGFSGGTMDMFNSILKFGSMIVNQLVNYKHP VFVYIPILGELRGGSWVVVDETLNSQIIEMYADTNSKGGILEPPGLVEVKFKFAEIKKLM NNSDPYIIELNQKLATLQNEEEILSVKKEIEKKEKEMLPFYLQVCHKYADLHDVSSCMKE KGVIRKIVPWEKSRSFFYYRLLRRLILHTLNKKFGDSYTNCDEIKDIINDLKNSEDDDQV VCKRVLNGNVLKNINKIKDEILHKKTLDGIFKEFQNLSKTQKIELYKKISSYEF
ID | Site | Peptide | Score | Method | ID | Site | Peptide | Score | Method | ID | Site | Peptide | Score | Method | ID | Site | Peptide | Score | Method | ID | Site | Peptide | Score | Method | ID | Site | Peptide | Score | Method | ID | Site | Peptide | Score | Method | ID | Site | Peptide | Score | Method | ID | Site | Peptide | Score | Method | ID | Site | Peptide | Score | Method | ID | Site | Peptide | Score | Method | ID | Site | Peptide | Score | Method | ID | Site | Peptide | Score | Method | ID | Site | Peptide | Score | Method | ID | Site | Peptide | Score | Method | ID | Site | Peptide | Score | Method | ID | Site | Peptide | Score | Method | ID | Site | Peptide | Score | Method | ID | Site | Peptide | Score | Method | ID | Site | Peptide | Score | Method | ID | Site | Peptide | Score | Method | ID | Site | Peptide | Score | Method | ID | Site | Peptide | Score | Method | ID | Site | Peptide | Score | Method | ID | Site | Peptide | Score | Method | ID | Site | Peptide | Score | Method | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PY17X_1337500 | 289 S | YKKFSTKNK | 0.996 | unsp | PY17X_1337500 | 289 S | YKKFSTKNK | 0.996 | unsp | PY17X_1337500 | 289 S | YKKFSTKNK | 0.996 | unsp | PY17X_1337500 | 337 S | PLSHSDKNG | 0.996 | unsp | PY17X_1337500 | 804 S | KLPISEKDN | 0.995 | unsp | PY17X_1337500 | 849 S | NSNDSFKPT | 0.994 | unsp | PY17X_1337500 | 1256 S | NESVSVQDI | 0.997 | unsp | PY17X_1337500 | 1270 S | KKDESQFCT | 0.991 | unsp | PY17X_1337500 | 1327 S | IESNSRDDT | 0.99 | unsp | PY17X_1337500 | 1466 S | YKNQSYKDK | 0.996 | unsp | PY17X_1337500 | 1474 S | KIVSSEIDF | 0.993 | unsp | PY17X_1337500 | 1502 S | EMSRSNDDN | 0.991 | unsp | PY17X_1337500 | 1590 S | NHLFSKKEI | 0.993 | unsp | PY17X_1337500 | 1743 S | LFLKSPSDI | 0.995 | unsp | PY17X_1337500 | 1785 S | AKPHSPNCL | 0.991 | unsp | PY17X_1337500 | 1894 S | NLEKSPIET | 0.996 | unsp | PY17X_1337500 | 1903 S | NKNDSTINN | 0.996 | unsp | PY17X_1337500 | 2022 S | ELKESIEDI | 0.997 | unsp | PY17X_1337500 | 2034 S | RLNPSIRDI | 0.993 | unsp | PY17X_1337500 | 2188 S | KIDYSRENS | 0.992 | unsp | PY17X_1337500 | 2192 S | SRENSEEIN | 0.993 | unsp | PY17X_1337500 | 2566 S | NSLHSSSDS | 0.997 | unsp | PY17X_1337500 | 2577 S | VEPESIKEC | 0.998 | unsp | PY17X_1337500 | 2712 S | KTAQSIEDF | 0.991 | unsp | PY17X_1337500 | 128 S | LSRISKSKS | 0.996 | unsp | PY17X_1337500 | 197 S | KDAQSGFRD | 0.99 | unsp |